Pcl-Ria, Inc.: FDA filings under this applicant name
FDA lists 29 510(k) clearances under the applicant name “Pcl-Ria, Inc.” (first 1977, latest 1983), across 15 product codes in 3 review panels. Median 510(k) review time under this name: 34 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| CEP | Radioimmunoassay, Luteinizing Hormone | 4 | 4 |
| JHI | Visual, Pregnancy Hcg, Prescription Use | 4 | 4 |
| CDP | Radioimmunoassay, Total Triiodothyronine | 3 | 3 |
| CDX | Radioimmunoassay, Total Thyroxine | 3 | 3 |
| JLW | Radioimmunoassay, Thyroid-Stimulating Hormone | 3 | 3 |
| CGJ | Radioimmunoassay, Follicle-Stimulating Hormone | 2 | 2 |
| JIT | Calibrator, Secondary | 2 | 2 |
| CGI | Radioimmunoassay, Estriol | 1 | 1 |
| DKA | Antiserum, Digoxin | 1 | 1 |
| DMP | Digoxin Control Serum, Ria | 1 | 1 |
Plus 5 more product codes.
Review panels
- Clinical Chemistry (24)
- Clinical Toxicology (4)
- Immunology (1)
Most recent Pcl-Ria, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K830526 | B-GCG SYSTEM BY RIA | JHI | 1983-04-05 | 47 |
| K823014 | DIGOXIN KIT | DPB | 1982-11-01 | 19 |
| K822935 | THYROID STIMULATING HORMONE | JLW | 1982-11-01 | 28 |
| K822612 | T3 UPTAKE KITS | KHQ | 1982-09-30 | 31 |
| K820886 | THYROXINE T4 KIT | CDX | 1982-04-16 | 17 |
| K820358 | FOLLICLE STIMULATING HORMONE KIT | CGJ | 1982-03-26 | 45 |
| K820357 | LUTEINIZING HORMONE KIT | CEP | 1982-03-25 | 44 |
| K812666 | THYROXINE (T4) 125I | CDP | 1981-10-02 | 11 |
| K810867 | FOLLICLE STIMULATING HORMONE (FSH) | JIS | 1981-04-14 | 14 |
| K810852 | FOLLICLE STIMULATING HORMONE ANTISERUM | CGJ | 1981-04-08 | 9 |
19 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Pcl-Ria, Inc..
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Frequently asked questions
How many FDA 510(k) clearances are listed under Pcl-Ria, Inc.?
FDA lists 29 510(k) clearances under the applicant name “Pcl-Ria, Inc.” (first 1977, latest 1983), across 15 product codes in 3 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Pcl-Ria, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Pcl-Ria, Inc. is 34 days.
Which FDA product codes appear under Pcl-Ria, Inc.?
The most frequent FDA product codes under this applicant name are CEP (Radioimmunoassay, Luteinizing Hormone, 4); JHI (Visual, Pregnancy Hcg, Prescription Use, 4); CDP (Radioimmunoassay, Total Triiodothyronine, 3).
Next steps
- See all 29 Pcl-Ria, Inc. clearances with predicates and recalls
- Run predicate analysis for product code CEP, Pcl-Ria, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.